Taipei, Monday, September 22, 2014 16:35 (GMT+8)
mostly cloudy
Taipei
29°C
Apex sees increase in revenues, but drop in profits in 2013 - related company info
Patty Wang, Taipei; Joseph Tsai, DIGITIMES [Thursday 26 June 2014]
  • Apex Biotechnology
  • Performance
    The company's stock price closed at NT$55.6 on the TSE on Friday, September 19, 2014.
    The company has reported consolidated revenues of NT$126 million for August 2014, representing a 22.7% drop on month and 18.1% drop on year.
    For the second quarter of 2014, the company totaled NT$442 million in consolidated revenues, up 4.5% sequentially and down 10.9% on year.
    Brief

    Full name: Apex Biotechnology

    Chinese name: 五鼎生物技術股份有限公司

    Short name: Apex

    Stock code: 1733

    Tax ID: 16130182

    Market: TSE

    Established: 2 Dec 1997

    Paid in capital: NT$985.31 million

    Listed on TSE: 17 Sep 2001

    Website: www.apexbio.com

  • Latest stock
    Apex [1733] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    22-Sep 64   55.60 55.90 55.30 55.60+0.00+0.00%  
    19-Sep 68 62 3,805,978 55.50 56.00 55.50 55.60+0.10+0.18% 55.60 55.50
    18-Sep 67 56 3,719,824 56.00 56.00 55.50 55.50-0.50-0.89% 55.80 55.50
    17-Sep 126 111 7,039,575 55.60 56.10 55.50 56.00+0.50+0.90% 56.00 55.60
    16-Sep 88 85 4,903,760 55.60 56.30 55.50 55.50-0.10-0.18% 55.80 55.50
    15-Sep 107 93 5,927,249 55.00 55.80 55.00 55.60+0.40+0.72% 55.70 55.50
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Aug 2013 - Aug 2014 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Aug-14

    126

    (22.7%)

    (18.1%)

    1,155

    (12.5%)

    Jul-14

    163

    5.8%

    11.9%

    1,029

    (11.8%)

    Jun-14

    154

    (3.9%)

    8.9%

    865

    (15.2%)

    May-14

    161

    25.9%

    (7%)

    711

    (19.1%)

    Apr-14

    127

    (7.8%)

    (30.1%)

    551

    (22%)

    Mar-14

    138

    9.7%

    (25.6%)

    423

    (19.2%)

    Feb-14

    126

    (20.7%)

    (20.4%)

    285

    (15.7%)

    Jan-14

    159

    26.5%

    (11.6%)

    159

    (11.6%)

    Dec-13

    126

    9.8%

    (20.5%)

    1,829

    (9.7%)

    Nov-13

    114

    (0%)

    (27.8%)

    1,704

    (8.8%)

    Oct-13

    114

    (25.9%)

    (30.9%)

    1,589

    (7%)

    Sep-13

    154

    0.3%

    8.4%

    1,475

    (4.5%)

    Aug-13

    154

    5.6%

    0.2%

    1,320

    (5.8%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, September 2014

    Apex: Consolidated revenues, 2Q13 - 2Q14 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    2Q-14

    442

    4.5%

    (10.9%)

    865

    (15.2%)

    1Q-14

    423

    19.4%

    (19.2%)

    423

    (19.2%)

    4Q-13

    354

    (22%)

    (26.5%)

    1,829

    (9.7%)

    3Q-13

    454

    (8.5%)

    (0.4%)

    1,475

    (4.5%)

    2Q-13

    497

    (5.2%)

    (9.9%)

    1,021

    (6.2%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, September 2014

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 2Q13 - 2Q14 (NT$k)

    Item

    2Q-2014

    1Q-2014

    4Q-2013

    3Q-2013

    2Q-2013

    Current assets

    1,716,112

    1,484,403

    1,447,851

    1,347,766

    1,644,885

    Intangible assets

    26,283

    25,088

    26,174

    17,236

    17,816

    Non-current assets

    1,254,992

    1,267,321

    1,276,137

    1,341,620

    1,027,811

    Assets

    2,971,104

    2,751,724

    2,723,988

    2,689,386

    2,672,696

    Current liabilities

    829,041

    347,770

    383,354

    382,837

    416,522

    Non-current liabilities

    421,448

    420,792

    420,118

    421,334

    421,188

    Liabilities

    1,250,489

    768,562

    803,472

    804,171

    837,710

    Stockholders' equity

    1,720,615

    1,983,162

    1,920,516

    1,885,215

    1,834,986

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, September 2014

    Apex: Consolidated income statement, 2Q13 - 2Q14 (NT$k)

    Item

    2Q-2014

    1Q-2014

    4Q-2013

    3Q-2013

    2Q-2013

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Operating revenue

    442,277

     

    423,222

     

    354,410

     

    454,277

     

    496,560

     

    Gross profit (loss) from operations

    138,765

     

    113,997

     

    106,527

     

    120,929

     

    169,175

     

    Operating expenses

    53,267

     

    54,100

     

    59,426

     

    51,361

     

    56,054

     

    Operating income (loss)

    85,498

     

    59,897

     

    48,747

     

    67,922

     

    113,121

     

    Non-operating expenses and losses

    -11,980

     

    12,345

     

    -3,812

     

    -8,211

     

    63,611

     

    Income from continuing operations before income tax

    73,518

     

    72,242

     

    44,935

     

    59,711

     

    176,732

     

    Net income (loss)

    62,496

     

    62,129

     

    30,322

     

    51,591

     

    163,005

     

    Diluted earnings per share (NT$)

    0.6

     

    0.6

     

    0.3

     

    0.5

     

    1.6

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, September 2014

  • Apex Biotechnology full profile
Realtime news
  • Commercial replacement demand upholding global PC shipments in 2014, says MIC

    IT + CE | 17min ago

  • LTPS panel technology currently sees oversupply in the market

    Displays | 28min ago

  • Digitimes Research: Intel, Rockchip look to expand x86 presence in tablet AP market

    Bits + chips | 49min ago

  • Notebook touch panel makers expect limited shipment growth in 2H14

    Displays | 1h 9min ago

  • TSMC, UMC ramping wafer production capacity in China

    Bits + chips | 1h 13min ago

  • Japan firms in new push for OLED

    Displays | 1h 19min ago

Pause
 | 
View more

22-Sep-2014 markets closed

 LastChange

TAIEX (TSE)9240.45+3.42+0.04% 

TSE electronic362.47+0.37+0.1% 

GTSM (OTC)141.52+1.27+0.91% 

OTC electronic179.37+1.25+0.7% 

Analysis of China revised domestic semiconductor industry goals
DIGITIMES Marketing Services
Greater China touch panel shipment forecast through 2015
  • 2014 global high brightness LED market, trends and shipment forecast

    For the global LED lighting market, the market size will reach US$25.82 billion in 2014 or a market penetration rate of 23.4%. This is attributable to exponential shipment growth for light bulbs, tubes, and directional lamps.

  • Greater China touch panel shipment forecast through 2015

    This Special Report provides forecasts through 2015 for Greater China touch panel shipments with breakdowns based on technology (glass, film, resistive), application (smartphone, NB and tablet) and by firm.

  • 2014 global tablet demand forecast

    This report analyzes the main players, their strategies and shipments forecasts for 2014, as well as other factors contributing to either growth or decline in various segments within the tablet market, with a particular focus on Apple, Google, Samsung, and Microsoft, along with whitebox vendors.